array:7 [ "_entity_form" => "wikifolio.edit" "_title_callback" => "\Drupal\Core\Entity\Controller\EntityController::editTitle" "wikifolio" => Drupal\wikifolio\Entity\Wikifolio {#1737 #entityTypeId: "wikifolio" #enforceIsNew: null #typedData: null #cacheContexts: [] #cacheTags: [] #cacheMaxAge: -1 #_serviceIds: [] #_entityStorages: [] #values: array:34 [ "id" => array:1 [ "x-default" => "8543" ] "isin" => array:1 [ "x-default" => "DE000LS9RVK4" ] "wkn" => array:1 [ "x-default" => "LS9RVK" ] "name" => array:1 [ "x-default" => "CLIMAX02" ] "short_description" => array:1 [ "x-default" => "Climax Institutes Invest Plus" ] "long_description" => array:1 [ "x-default" => """ Climax Institutes Invest Plus ist stark an mein seit Jahrzehnten angelegtes reales, hochspekulatives, breit diversifiziertes, technologielastiges und chancenorientiertes Portfolio angelehnt. Die Titel sollten dabei typischerweise über viele Jahre gehalten werden. Neben Aktien mit technologisch interessanten, teilweise einzigartigen Ansätzen können auch immer wieder hochspekulative Turnaround-, Penny-Stocks sowie Beteiligungs- und Venture Capital-AGs beigemischt sein.\r\n In der Plus Variante soll durch gezielte Gewichtung (bis auf "0") und Beimischung von Krypto, Gold und Rohstoff-ETFs bzw. ETCs auch in Abhängigkeit von der jeweiligen allgemeinen globalen wirtschaftlichen Situation, zusätzliche Stabilität und Ertrag generiert werden. Die Auswahl der Titel soll in erster Line durch meine persönliche Einschätzung des zukünftigen Potentials und der daraus resultierenden Aussichten erfolgen. Das Chance/Risiko Verhältnis ist eine entscheidende Größe bei meiner Auswahl und das nach meiner subjektiven Einschätzung. Ich suche nach längerfristigen großen Chancen mit entsprechenden großen Risiken, zumindest in den einzelnen Titeln. Meine Einschätzung muss dabei nicht unbedingt dem allgemeinen Konsens entsprechen. \r\n Ich erwarte von "Climax Institutes Invest Plus" mittel- und langfristig eine deutliche Outperformance, bei gleichzeitig deutlich erhöhter Volatilität, gegenüber anderen Portfolios und Indizes ohne entsprechende Beimischung. Aufgrund des Vorgehens nahezu aller Notenbanken und der daraus resultierenden extremen Geldmengenausweitung seit 2000 (New Economy Krise), 2008 (Subprime Krise) und nun 2020 (Corona Krise) befürchte ich Schlimmes.\r\n Unter vielen Experten scheint es diesbezüglich einen Konsens zu geben, nur der Zeithorizont differiert. \r\n Dass zudem immer mehr Akteure zu glauben scheinen "Diesmal ist alles anders", macht die Sache keinesfalls besser.\r\n "Climax Institutes Invest Plus" versucht diese möglichen zukünftigen Verwerfungen möglichst zu kompensieren oder gar in Gewinne zu verwandeln. """ ] "status" => array:1 [ "x-default" => "Investable" ] "trader_name" => array:1 [ "x-default" => "SupaFlash" ] "symbol" => array:1 [ "x-default" => "WFCLIMAX02" ] "creation_date" => array:1 [ "x-default" => "1612187153" ] "issuing_date" => array:1 [ "x-default" => "1624512323" ] "daily_free_relative" => array:1 [ "x-default" => "0.95" ] "performance_free_relative" => array:1 [ "x-default" => "10" ] "cash" => array:1 [ "x-default" => "-241.694" ] "url" => array:1 [ "x-default" => "https://www.wikifolio.com/de/ch/w/wfclimax02" ] "href" => array:1 [ "x-default" => "https://api.wikifolio.com/api/v1/wikifolios/de000ls9rvk4" ] "wikifolio_tags" => array:1 [ "x-default" => "a:10:{i:0;a:3:{s:4:"Name";s:3:"etf";s:16:"ShortDescription";s:4:"ETFs";s:8:"TagGroup";s:15:"Anlageuniversum";}i:1;a:3:{s:4:"Name";s:6:"akteur";s:16:"ShortDescription";s:13:"Aktien Europa";s:8:"TagGroup";s:15:"Anlageuniversum";}i:2;a:3:{s:4:"Name";s:5:"aktde";s:16:"ShortDescription";s:18:"Aktien Deutschland";s:8:"TagGroup";s:15:"Anlageuniversum";}i:3;a:3:{s:4:"Name";s:6:"divers";s:16:"ShortDescription";s:20:"Aktiv diversifiziert";s:8:"TagGroup";s:11:"Handelsstil";}i:4;a:3:{s:4:"Name";s:8:"sonstige";s:16:"ShortDescription";s:16:"Sonstige Analyse";s:8:"TagGroup";s:20:"Entscheidungsfindung";}i:5;a:3:{s:4:"Name";s:6:"aktint";s:16:"ShortDescription";s:20:"Aktien International";s:8:"TagGroup";s:15:"Anlageuniversum";}i:6;a:3:{s:4:"Name";s:6:"akthot";s:16:"ShortDescription";s:17:"Aktien Hot Stocks";s:8:"TagGroup";s:15:"Anlageuniversum";}i:7;a:3:{s:4:"Name";s:8:"langf-st";s:16:"ShortDescription";s:23:"Mittel- bis langfristig";s:8:"TagGroup";s:36:"ExtendedSearchInvestmentHorizonGroup";}i:8;a:3:{s:4:"Name";s:6:"aktusa";s:16:"ShortDescription";s:10:"Aktien USA";s:8:"TagGroup";s:15:"Anlageuniversum";}i:9;a:3:{s:4:"Name";s:10:"regelm-akt";s:16:"ShortDescription";s:24:"Regelmäßige Aktivität";s:8:"TagGroup";s:18:"Qualitätsmerkmale";}}" ] "rankings" => array:1 [ "x-default" => "a:9:{i:0;a:4:{s:4:"Name";s:3:"aum";s:16:"ShortDescription";s:19:"Summe Investitionen";s:5:"Value";d:10177.166876;s:5:"Index";i:2262;}i:1;a:4:{s:4:"Name";s:8:"topwikis";s:16:"ShortDescription";s:23:"Top-wikifolio-Rangliste";s:5:"Value";d:103.273273335948;s:5:"Index";i:2100;}i:2;a:4:{s:4:"Name";s:6:"perf1m";s:16:"ShortDescription";s:19:"Performance 1 Monat";s:5:"Value";d:-6.891526715;s:5:"Index";i:60768;}i:3;a:4:{s:4:"Name";s:7:"perf12m";s:16:"ShortDescription";s:18:"Performance 1 Jahr";s:5:"Value";d:-2.855845555;s:5:"Index";i:51216;}i:4;a:4:{s:4:"Name";s:8:"perfever";s:16:"ShortDescription";s:23:"Performance seit Beginn";s:5:"Value";d:-3.074601176927;s:5:"Index";i:64431;}i:5;a:4:{s:4:"Name";s:6:"perf3m";s:16:"ShortDescription";s:20:"Performance 3 Monate";s:5:"Value";d:-1.381159172;s:5:"Index";i:54084;}i:6;a:4:{s:4:"Name";s:6:"perf6m";s:16:"ShortDescription";s:20:"Performance 6 Monate";s:5:"Value";d:-5.336464509;s:5:"Index";i:53630;}i:7;a:4:{s:4:"Name";s:7:"maxdraw";s:16:"ShortDescription";s:26:"maximaler Verlust (bisher)";s:5:"Value";d:-54.2337678939;s:5:"Index";i:82251;}i:8;a:4:{s:4:"Name";s:11:"sharperatio";s:16:"ShortDescription";s:23:"Sharpe Ratio (365 Tage)";s:5:"Value";d:-0.187119838763;s:5:"Index";i:32967;}}" ] "wikifolio_items" => array:1 [ "x-default" => "a:44:{i:0;a:8:{s:4:"ISIN";s:12:"NL0015000YE1";s:3:"WKN";s:6:"A3DMC3";s:16:"ShortDescription";s:25:"TME PHARM.CONF.IPO EO 1,-";s:13:"AbsoluteValue";d:26640;s:13:"RelativeValue";d:-110.22223060240259;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:400000;}i:1;a:8:{s:4:"ISIN";s:12:"US01609W1027";s:3:"WKN";s:6:"A117ME";s:16:"ShortDescription";s:24:"ALIBABA GR.HLDG SP.ADR 8";s:13:"AbsoluteValue";d:15295.5;s:13:"RelativeValue";d:-63.28468949621054;s:12:"AbsoluteGain";d:3078.99999999999;s:12:"RelativeGain";d:0.2520361805754502;s:8:"Quantity";d:165;}i:2;a:8:{s:4:"ISIN";s:12:"KYG608371046";s:3:"WKN";s:6:"A1C5AB";s:16:"ShortDescription";s:25:"MICRP.SCIEN.REGS HD-00001";s:13:"AbsoluteValue";d:2518.5;s:13:"RelativeValue";d:-10.420221012468128;s:12:"AbsoluteGain";d:-1148.999999997;s:12:"RelativeGain";d:-0.3132924335372706;s:8:"Quantity";d:3450;}i:3;a:8:{s:4:"ISIN";s:12:"KYG6683N1034";s:3:"WKN";s:6:"A3C82G";s:16:"ShortDescription";s:25:"NU HLDGS CL.A DL-,000066";s:13:"AbsoluteValue";d:11015;s:13:"RelativeValue";d:-45.574244372577496;s:12:"AbsoluteGain";d:-681;s:12:"RelativeGain";d:-0.058225034199726404;s:8:"Quantity";d:1000;}i:4;a:8:{s:4:"ISIN";s:12:"KYG970081173";s:3:"WKN";s:6:"A2QJCN";s:16:"ShortDescription";s:24:"WUXI BIOLOGICS-0,0000083";s:13:"AbsoluteValue";d:2724;s:13:"RelativeValue";d:-11.270471327362786;s:12:"AbsoluteGain";d:-227.2199999992;s:12:"RelativeGain";d:-0.07699188810026417;s:8:"Quantity";d:800;}i:5;a:8:{s:4:"ISIN";s:12:"KYG9830T1067";s:3:"WKN";s:6:"A2JNY1";s:16:"ShortDescription";s:17:"XIAOMI CORP. CL.B";s:13:"AbsoluteValue";d:40560;s:13:"RelativeValue";d:-167.81582857482917;s:12:"AbsoluteGain";d:-7260;s:12:"RelativeGain";d:-0.15181932245922208;s:8:"Quantity";d:15000;}i:6;a:8:{s:4:"ISIN";s:12:"US20602D1019";s:3:"WKN";s:6:"A2QG33";s:16:"ShortDescription";s:25:"CONCENTRIX CORP. DL-,0001";s:13:"AbsoluteValue";d:435.4;s:13:"RelativeValue";d:-1.801454925085814;s:12:"AbsoluteGain";d:-228.6;s:12:"RelativeGain";d:-0.34427710843373494;s:8:"Quantity";d:20;}i:7;a:8:{s:4:"ISIN";s:12:"US09075V1026";s:3:"WKN";s:6:"A2PSR2";s:16:"ShortDescription";s:24:"BIONTECH SE SPON. ADRS 1";s:13:"AbsoluteValue";d:48701;s:13:"RelativeValue";d:-201.49898095223756;s:12:"AbsoluteGain";d:-13946.6615384613;s:12:"RelativeGain";d:-0.222620624552746;s:8:"Quantity";d:620;}i:8;a:8:{s:4:"ISIN";s:12:"US12468P1049";s:3:"WKN";s:6:"A2QJVE";s:16:"ShortDescription";s:25:"C3 AI INC. CL.A DL -,001";s:13:"AbsoluteValue";d:5552.5;s:13:"RelativeValue";d:-22.973308386630645;s:12:"AbsoluteGain";d:614.05;s:12:"RelativeGain";d:0.12434063319462585;s:8:"Quantity";d:625;}i:9;a:8:{s:4:"ISIN";s:12:"US3847471014";s:3:"WKN";s:6:"A40F8M";s:16:"ShortDescription";s:17:"GRAIL INC. DL-,01";s:13:"AbsoluteValue";d:27620;s:13:"RelativeValue";d:-114.27695229873721;s:12:"AbsoluteGain";d:17620;s:12:"RelativeGain";d:1.762;s:8:"Quantity";d:500;}i:10;a:8:{s:4:"ISIN";s:12:"US3741631036";s:3:"WKN";s:6:"902213";s:16:"ShortDescription";s:25:"GERON CORP. (DEL.) DL-001";s:13:"AbsoluteValue";d:328.5;s:13:"RelativeValue";d:-1.3591592624958426;s:12:"AbsoluteGain";d:1.8;s:12:"RelativeGain";d:0.005509641873278237;s:8:"Quantity";d:300;}i:11;a:8:{s:4:"ISIN";s:12:"US88554D2053";s:3:"WKN";s:6:"888346";s:16:"ShortDescription";s:25:"3 D SYS CORP. DL-,001";s:13:"AbsoluteValue";d:15380;s:13:"RelativeValue";d:-63.634305805741434;s:12:"AbsoluteGain";d:-2640;s:12:"RelativeGain";d:-0.146503884572697;s:8:"Quantity";d:5000;}i:12;a:8:{s:4:"ISIN";s:12:"US88688T2096";s:3:"WKN";s:6:"A41VMJ";s:16:"ShortDescription";s:23:"TILRAY BRANDS NEW O.N.";s:13:"AbsoluteValue";d:12300;s:13:"RelativeValue";d:-50.890894760118314;s:12:"AbsoluteGain";d:-11487.39999999;s:12:"RelativeGain";d:-0.4829195288259679;s:8:"Quantity";d:3000;}i:13;a:8:{s:4:"ISIN";s:12:"US69608A1088";s:3:"WKN";s:6:"A2QA4J";s:16:"ShortDescription";s:25:"PALANTIR TECHNOLOGIES INC";s:13:"AbsoluteValue";d:121404.2;s:13:"RelativeValue";d:-502.3063711899476;s:12:"AbsoluteGain";d:92522.58907562973;s:12:"RelativeGain";d:3.203512065788521;s:8:"Quantity";d:1090;}i:14;a:8:{s:4:"ISIN";s:12:"US7479066000";s:3:"WKN";s:6:"A40M9N";s:16:"ShortDescription";s:18:"QUANTUM CORP. DL0";s:13:"AbsoluteValue";d:33275;s:13:"RelativeValue";d:-137.6743514750355;s:12:"AbsoluteGain";d:20870.5000000025;s:12:"RelativeGain";d:1.6824942561172724;s:8:"Quantity";d:2500;}i:15;a:8:{s:4:"ISIN";s:12:"US77543R1023";s:3:"WKN";s:6:"A2DW4X";s:16:"ShortDescription";s:25:"ROKU INC CL. A DL-,0001";s:13:"AbsoluteValue";d:23996;s:13:"RelativeValue";d:-99.2827569645365;s:12:"AbsoluteGain";d:11211.5;s:12:"RelativeGain";d:0.8769603817122297;s:8:"Quantity";d:200;}i:16;a:8:{s:4:"ISIN";s:12:"US85916J4094";s:3:"WKN";s:6:"A1J09L";s:16:"ShortDescription";s:25:"STEREOTAXIS DL-,01";s:13:"AbsoluteValue";d:12165;s:13:"RelativeValue";d:-50.33233615909262;s:12:"AbsoluteGain";d:-4734.9999999975;s:12:"RelativeGain";d:-0.2801775147927929;s:8:"Quantity";d:7500;}i:17;a:8:{s:4:"ISIN";s:12:"DE000A0XYG76";s:3:"WKN";s:6:"A0XYG7";s:16:"ShortDescription";s:22:"DT.ROHSTOFF AG NA O.N.";s:13:"AbsoluteValue";d:30065;s:13:"RelativeValue";d:-124.39306918398024;s:12:"AbsoluteGain";d:20790;s:12:"RelativeGain";d:2.241509433962264;s:8:"Quantity";d:350;}i:18;a:8:{s:4:"ISIN";s:12:"DE000A0Z2ZZ5";s:3:"WKN";s:6:"A0Z2ZZ";s:16:"ShortDescription";s:18:"FREENET AG NA O.N.";s:13:"AbsoluteValue";d:250;s:13:"RelativeValue";d:-1.0343677796772015;s:12:"AbsoluteGain";d:-16.4;s:12:"RelativeGain";d:-0.06156156156156156;s:8:"Quantity";d:10;}i:19;a:8:{s:4:"ISIN";s:12:"DE000A1EWVY8";s:3:"WKN";s:6:"A1EWVY";s:16:"ShortDescription";s:11:"FORMYCON AG";s:13:"AbsoluteValue";d:29250;s:13:"RelativeValue";d:-121.02103022223257;s:12:"AbsoluteGain";d:-42244.9999999995;s:12:"RelativeGain";d:-0.5908804811525253;s:8:"Quantity";d:1500;}i:20;a:8:{s:4:"ISIN";s:12:"DE000A255G02";s:3:"WKN";s:6:"A255G0";s:16:"ShortDescription";s:20:"ENAPTER AG INH O.N.";s:13:"AbsoluteValue";d:5300;s:13:"RelativeValue";d:-21.928596929156672;s:12:"AbsoluteGain";d:-1295;s:12:"RelativeGain";d:-0.19636087945413191;s:8:"Quantity";d:4000;}i:21;a:8:{s:4:"ISIN";s:12:"DE000A37FT41";s:3:"WKN";s:6:"A37FT4";s:16:"ShortDescription";s:22:"EPIGENOMICS AG NA O.N.";s:13:"AbsoluteValue";d:2436;s:13:"RelativeValue";d:-10.07887964517465;s:12:"AbsoluteGain";N;s:12:"RelativeGain";N;s:8:"Quantity";d:2800;}i:22;a:8:{s:4:"ISIN";s:12:"DE000A3E5A34";s:3:"WKN";s:6:"A3E5A3";s:16:"ShortDescription";s:17:"PARTEC AG NA O.N.";s:13:"AbsoluteValue";d:13500;s:13:"RelativeValue";d:-55.855860102568876;s:12:"AbsoluteGain";d:-9026.999999999;s:12:"RelativeGain";d:-0.40071913703553075;s:8:"Quantity";d:1000;}i:23;a:8:{s:4:"ISIN";s:12:"DE000A3H2101";s:3:"WKN";s:6:"A3H210";s:16:"ShortDescription";s:23:"AAP IMPLANTATE AG KONV.";s:13:"AbsoluteValue";d:24900;s:13:"RelativeValue";d:-103.02303085584927;s:12:"AbsoluteGain";d:-13990.000000005;s:12:"RelativeGain";d:-0.35973257906925177;s:8:"Quantity";d:15000;}i:24;a:8:{s:4:"ISIN";s:12:"DE000A40AEG0";s:3:"WKN";s:6:"A40AEG";s:16:"ShortDescription";s:25:"PENTIXAPHARM HLDG NA O.N.";s:13:"AbsoluteValue";d:15120;s:13:"RelativeValue";d:-62.55856331487714;s:12:"AbsoluteGain";d:-4594.000000002;s:12:"RelativeGain";d:-0.2330323627879443;s:8:"Quantity";d:7000;}i:25;a:8:{s:4:"ISIN";s:12:"DE000A4BGGM7";s:3:"WKN";s:6:"A4BGGM";s:16:"ShortDescription";s:25:"BIOFRONTERA AG NA ON KONV";s:13:"AbsoluteValue";d:12022.8664;s:13:"RelativeValue";d:-49.744262494094514;s:12:"AbsoluteGain";d:-64356.13359999224;s:12:"RelativeGain";d:-0.8425893714240665;s:8:"Quantity";d:5182.27;}i:26;a:8:{s:4:"ISIN";s:12:"CH1114873776";s:3:"WKN";s:6:"A3GSS0";s:16:"ShortDescription";s:22:"21SHARES SOLANA ETP OE";s:13:"AbsoluteValue";d:10290.5;s:13:"RelativeValue";d:-42.57664654707297;s:12:"AbsoluteGain";d:-6847;s:12:"RelativeGain";d:-0.39953318745441285;s:8:"Quantity";d:250;}i:27;a:8:{s:4:"ISIN";s:12:"CH0454664001";s:3:"WKN";s:6:"A2T64E";s:16:"ShortDescription";s:23:"21SHARES BITCOIN ETP OE";s:13:"AbsoluteValue";d:116985.6;s:13:"RelativeValue";d:-484.02454130482084;s:12:"AbsoluteGain";d:53488.4571428544;s:12:"RelativeGain";d:0.8423758099351256;s:8:"Quantity";d:6400;}i:28;a:8:{s:4:"ISIN";s:12:"CH0454664027";s:3:"WKN";s:6:"A2T68Z";s:16:"ShortDescription";s:21:"21SHARES ETHER ETP OE";s:13:"AbsoluteValue";d:104353.2;s:13:"RelativeValue";d:-431.75835114484374;s:12:"AbsoluteGain";d:21126.6242840205;s:12:"RelativeGain";d:0.25384468965919726;s:8:"Quantity";d:6300;}i:29;a:8:{s:4:"ISIN";s:12:"CNE100000296";s:3:"WKN";s:6:"A0M4W9";s:16:"ShortDescription";s:3:"BYD";s:13:"AbsoluteValue";d:17734;s:13:"RelativeValue";d:-73.37391281918197;s:12:"AbsoluteGain";d:-35426;s:12:"RelativeGain";d:-0.66640331075997;s:8:"Quantity";d:2000;}i:30;a:8:{s:4:"ISIN";s:12:"DE0005203947";s:3:"WKN";s:6:"520394";s:16:"ShortDescription";s:21:"BRAIN BIOTEC NA O.N.";s:13:"AbsoluteValue";d:19244;s:13:"RelativeValue";d:-79.62149420843225;s:12:"AbsoluteGain";d:-24515.9999999996;s:12:"RelativeGain";d:-0.5602376599634329;s:8:"Quantity";d:6800;}i:31;a:8:{s:4:"ISIN";s:12:"DE0005659700";s:3:"WKN";s:6:"565970";s:16:"ShortDescription";s:24:"ECKERT+ZIEGLER INH O.N.";s:13:"AbsoluteValue";d:7084;s:13:"RelativeValue";d:-29.30984540493318;s:12:"AbsoluteGain";d:-1032.99999999998;s:12:"RelativeGain";d:-0.12726376740174727;s:8:"Quantity";d:460;}i:32;a:8:{s:4:"ISIN";s:12:"DE0005664809";s:3:"WKN";s:6:"566480";s:16:"ShortDescription";s:19:"EVOTEC SE INH O.N.";s:13:"AbsoluteValue";d:8004;s:13:"RelativeValue";d:-33.11631883414528;s:12:"AbsoluteGain";d:-43245.59999999952;s:12:"RelativeGain";d:-0.8438231713027989;s:8:"Quantity";d:1740;}i:33;a:8:{s:4:"ISIN";s:12:"DE0005932735";s:3:"WKN";s:6:"593273";s:16:"ShortDescription";s:11:"YOC AG O.N.";s:13:"AbsoluteValue";d:5040;s:13:"RelativeValue";d:-20.852854438292383;s:12:"AbsoluteGain";d:542.6000000008;s:12:"RelativeGain";d:0.12064748521387836;s:8:"Quantity";d:800;}i:34;a:8:{s:4:"ISIN";s:12:"CA67059R1091";s:3:"WKN";s:6:"A3DNSU";s:16:"ShortDescription";s:22:"NUREXONE BIOLOGIC INC.";s:13:"AbsoluteValue";d:16250;s:13:"RelativeValue";d:-67.2339056790181;s:12:"AbsoluteGain";d:6790;s:12:"RelativeGain";d:0.7177589852008457;s:8:"Quantity";d:50000;}i:35;a:8:{s:4:"ISIN";s:12:"CA73044W3021";s:3:"WKN";s:6:"A3DWD8";s:16:"ShortDescription";s:15:"POET TECHS INC.";s:13:"AbsoluteValue";d:156940;s:13:"RelativeValue";d:-649.33471737016;s:12:"AbsoluteGain";d:102260.76666666174;s:12:"RelativeGain";d:1.8701938639712559;s:8:"Quantity";d:14750;}i:36;a:8:{s:4:"ISIN";s:12:"CA81752F1062";s:3:"WKN";s:6:"A411DW";s:16:"ShortDescription";s:23:"SERNOVA BIOTHERAPEUTICS";s:13:"AbsoluteValue";d:12750;s:13:"RelativeValue";d:-52.75275676353727;s:12:"AbsoluteGain";d:-34014.3999999;s:12:"RelativeGain";d:-0.7273567072382567;s:8:"Quantity";d:150000;}i:37;a:8:{s:4:"ISIN";s:12:"AU000000TLG7";s:3:"WKN";s:6:"A1C0Q2";s:16:"ShortDescription";s:20:"TALGA RESOURCES LTD.";s:13:"AbsoluteValue";d:4110;s:13:"RelativeValue";d:-17.005006297893193;s:12:"AbsoluteGain";d:-4290;s:12:"RelativeGain";d:-0.5107142857142857;s:8:"Quantity";d:30000;}i:38;a:8:{s:4:"ISIN";s:12:"AU000000DRO2";s:3:"WKN";s:6:"A2DMAA";s:16:"ShortDescription";s:15:"DRONESHIELD LTD";s:13:"AbsoluteValue";d:68468.4;s:13:"RelativeValue";d:-283.286027544202;s:12:"AbsoluteGain";d:50585.8000000078;s:12:"RelativeGain";d:2.8287721024923593;s:8:"Quantity";d:41800;}i:39;a:8:{s:4:"ISIN";s:12:"CA0585861085";s:3:"WKN";s:6:"A0RENB";s:16:"ShortDescription";s:15:"BALLARD PWR SYS";s:13:"AbsoluteValue";d:30416;s:13:"RelativeValue";d:-125.84532154664704;s:12:"AbsoluteGain";d:-30897.5;s:12:"RelativeGain";d:-0.5039265414631362;s:8:"Quantity";d:8000;}i:40;a:8:{s:4:"ISIN";s:12:"CA24463V1013";s:3:"WKN";s:6:"A3CN14";s:16:"ShortDescription";s:25:"DEFENCE THERAPEUTICS A";s:13:"AbsoluteValue";d:4247.1;s:13:"RelativeValue";d:-17.57225358826817;s:12:"AbsoluteGain";d:-13095.3999999966;s:12:"RelativeGain";d:-0.7551045120368556;s:8:"Quantity";d:14300;}i:41;a:8:{s:4:"ISIN";s:12:"DE000EWG0LD1";s:3:"WKN";s:6:"EWG0LD";s:16:"ShortDescription";s:10:"EUWAX GOLD";s:13:"AbsoluteValue";d:115959;s:13:"RelativeValue";d:-479.7770134543544;s:12:"AbsoluteGain";d:64949;s:12:"RelativeGain";d:1.2732601450695942;s:8:"Quantity";d:1000;}i:42;a:8:{s:4:"ISIN";s:12:"FR0011271600";s:3:"WKN";s:6:"A1103M";s:16:"ShortDescription";s:25:"FERMENTALG EO -,04";s:13:"AbsoluteValue";d:30322.5;s:13:"RelativeValue";d:-125.45846799704776;s:12:"AbsoluteGain";d:-30827.499999985;s:12:"RelativeGain";d:-0.5041291905150052;s:8:"Quantity";d:65000;}i:43;a:8:{s:4:"ISIN";s:12:"FR0013333077";s:3:"WKN";s:6:"A3CRZT";s:16:"ShortDescription";s:25:"CARVOLIX S.A. EO 1";s:13:"AbsoluteValue";d:35300;s:13:"RelativeValue";d:-146.05273049042086;s:12:"AbsoluteGain";d:21060;s:12:"RelativeGain";d:1.478932584269663;s:8:"Quantity";d:10000;}}" ] "licence_switzerland" => array:1 [ "x-default" => "0" ] "perf1m" => array:1 [ "x-default" => "-6.89153" ] "perf12m" => array:1 [ "x-default" => "-2.85585" ] "perfever" => array:1 [ "x-default" => "-3.0746" ] "aum" => array:1 [ "x-default" => "10177.2" ] "topwikis" => array:1 [ "x-default" => "2100" ] "created" => array:1 [ "x-default" => "1649766873" ] "changed" => array:1 [ "x-default" => "1781990684" ] "solid_valor" => array:1 [ "x-default" => "112327161" ] "solid_bc" => array:1 [ "x-default" => "LSD" ] "solid_bc_id" => array:1 [ "x-default" => "2913" ] "solid_cc" => array:1 [ "x-default" => "EUR" ] "solid_cc_id" => array:1 [ "x-default" => "814" ] "fullquote_link" => array:1 [ "x-default" => "wikifolio/wfcli-lgsz-open-112327161/lsd/eur" ] "solid_changed" => array:1 [ "x-default" => "1661264169" ] ] #fields: [] #fieldDefinitions: null #languages: array:4 [ "en" => Drupal\Core\Language\Language {#1742 #name: "English" #id: "en" #direction: "ltr" #weight: 0 #locked: false } "de" => Drupal\Core\Language\Language {#1741 #name: "German" #id: "de" #direction: "ltr" #weight: 1 #locked: false } "und" => Drupal\Core\Language\Language {#1743 #name: "Not specified" #id: "und" #direction: "ltr" #weight: 2 #locked: true } "zxx" => Drupal\Core\Language\Language {#1735 #name: "Not applicable" #id: "zxx" #direction: "ltr" #weight: 3 #locked: true } ] #langcodeKey: "" #defaultLangcodeKey: "default_langcode" #activeLangcode: "x-default" #enforceDefaultTranslation: null #defaultLangcode: "und" #translations: array:1 [ "x-default" => array:1 [ "status" => 1 ] ] #translationInitialize: false #newRevision: false #isDefaultRevision: true #entityKeys: array:3 [ "bundle" => "wikifolio" "id" => "8543" "label" => "8543" ] #translatableEntityKeys: [] #validated: false #validationRequired: false #loadedRevisionId: null #revisionTranslationAffectedKey: "revision_translation_affected" #enforceRevisionTranslationAffected: [] #isSyncing: false } "_route" => "entity.wikifolio.edit_form" "_route_object" => Symfony\Component\Routing\Route {#1598 -path: "/admin/content/wikifolio/{wikifolio}/edit" -host: "" -schemes: [] -methods: array:2 [ 0 => "GET" 1 => "POST" ] -defaults: array:2 [ "_entity_form" => "wikifolio.edit" "_title_callback" => "\Drupal\Core\Entity\Controller\EntityController::editTitle" ] -requirements: array:2 [ "_entity_access" => "wikifolio.update" "wikifolio" => "\d+" ] -options: array:5 [ "compiler_class" => "Drupal\Core\Routing\RouteCompiler" "parameters" => array:1 [ "wikifolio" => array:2 [ "type" => "entity:wikifolio" "converter" => "paramconverter.entity" ] ] "_admin_route" => true "_access_checks" => array:1 [ 0 => "access_check.entity" ] "utf8" => true ] -condition: "" -compiled: Drupal\Core\Routing\CompiledRoute {#1593 -variables: array:1 [ 0 => "wikifolio" ] -tokens: array:3 [ 0 => array:2 [ 0 => "text" 1 => "/edit" ] 1 => array:5 [ 0 => "variable" 1 => "/" 2 => "\d+" 3 => "wikifolio" 4 => true ] 2 => array:2 [ 0 => "text" 1 => "/admin/content/wikifolio" ] ] -staticPrefix: "" -regex: "{^/admin/content/wikifolio/(?P<wikifolio>\d+)/edit$}sDu" -pathVariables: array:1 [ 0 => "wikifolio" ] -hostVariables: [] -hostRegex: null -hostTokens: [] #fit: 29 #patternOutline: "/admin/content/wikifolio/%/edit" #numParts: 5 } } "_raw_variables" => Symfony\Component\HttpFoundation\InputBag {#1592 #parameters: array:1 [ "wikifolio" => "8543" ] } "_controller" => "controller.entity_form:getContentResult" ]